Form D · Other
Jocasta Neuroscience, Inc.
Northbrook, IL · CIK 0002043612
Offering snapshot reported Nov 12, 2024 · SEC filing
- Reported sold
- $31.6M Offering amount: $40.1M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Oct 28, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2024 | Initial | $31,649,919 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-529122
Total Offering Amount and Total Amount Sold include conversion of the previously issued Simple Agreements for Future Equity.
Source: Form D, filed Nov 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Albert Agro | Director, Executive |
| Michael Davidson | Director, Executive |
| Jonathan Jonas | Executive |
| Kevin Rose | Director |
Issuer details
Industry: Other (See others in industry)
Address:
650 Dundee Road, Suite 380
Northbrook, IL, 60062
Northbrook, IL, 60062